PMID- 28566450 OWN - NLM STAT- MEDLINE DCOM- 20170828 LR - 20220330 IS - 1470-8736 (Electronic) IS - 0143-5221 (Linking) VI - 131 IP - 12 DP - 2017 Jun 1 TI - Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease. PG - 1215-1224 LID - 10.1042/CS20170009 [doi] AB - Monocytes circulate in the blood and migrate to inflammatory tissues, but their functions can be either detrimental or beneficial, depending on their phenotypes. In humans, classical monocytes are inflammatory cluster of differentiation (CD)14(++)CD16(-)CCR2(++) cells originated from the bone marrow or spleen reservoirs and comprise >/=92% of monocytes. Intermediate monocytes (CD14(++)CD16(+)CCR2(+)) are involved in the production of anti-inflammatory cytokines [such as interleukin (IL)-10], reactive oxygen species (ROS), and proinflammatory mediators [such as tumor necrosis factor-alpha (TNF-alpha) and IL-1beta). Nonclassical monocytes (CD14(+)CD16(++)CCR2(-)) are patrolling cells involved in tissue repair and debris removal from the vasculature. Many studies in both humans and animals have shown the importance of monocyte chemoattractant protein-1 (MCP-1) and its receptor [chemokine receptor of MCP-1 (CCR2)] in pathologies, such as atherosclerosis and myocardial infarction (MI). This review presents the importance of these monocyte subsets in cardiovascular diseases (CVDs), and sheds light on new strategies for the blocking of the MCP-1/CCR2 axis as a therapeutic goal for treating vascular disorders. CI - (c) 2017 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society. FAU - Franca, Carolina N AU - Franca CN AD - Santo Amaro University-Health Sciences Post Graduation, Sao Paulo - SP, Brazil carolufscar24@gmail.com. AD - Federal University of Sao Paulo, Department of Medicine, Cardiology Division, Sao Paulo - SP, Brazil. FAU - Izar, Maria C O AU - Izar MCO AD - Federal University of Sao Paulo, Department of Medicine, Cardiology Division, Sao Paulo - SP, Brazil. FAU - Hortencio, Marinella N S AU - Hortencio MNS AD - Santo Amaro University-Health Sciences Post Graduation, Sao Paulo - SP, Brazil. FAU - do Amaral, Jonatas B AU - do Amaral JB AD - Federal University of Sao Paulo, Department of Otorhinolaryngology, Head and Neck Surgery, Sao Paulo - SP, Brazil. FAU - Ferreira, Carlos E S AU - Ferreira CES AD - Albert Einstein Israeli Hospital, Sao Paulo - SP, Brazil. FAU - Tuleta, Izabela D AU - Tuleta ID AD - Medizinische Klinik und Poliklinik II-Universitatsklinikum Bonn, Bonn - North Rhine-Westphalia, Germany. FAU - Fonseca, Francisco A H AU - Fonseca FAH AD - Federal University of Sao Paulo, Department of Medicine, Cardiology Division, Sao Paulo - SP, Brazil. LA - eng PT - Journal Article PT - Review PL - England TA - Clin Sci (Lond) JT - Clinical science (London, England : 1979) JID - 7905731 RN - 0 (Anti-Inflammatory Agents) RN - 0 (CCL2 protein, human) RN - 0 (CCR2 protein, human) RN - 0 (Cardiovascular Agents) RN - 0 (Chemokine CCL2) RN - 0 (Ligands) RN - 0 (Receptors, CCR2) SB - IM MH - Animals MH - Anti-Inflammatory Agents/therapeutic use MH - Cardiovascular Agents/therapeutic use MH - Cardiovascular Diseases/drug therapy/immunology/*metabolism MH - Chemokine CCL2/antagonists & inhibitors/*metabolism MH - Humans MH - Ligands MH - Monocytes/classification/drug effects/immunology/*metabolism MH - Phenotype MH - Receptors, CCR2/antagonists & inhibitors/*metabolism MH - Signal Transduction OTO - NOTNLM OT - atherosclerosis OT - chemokine receptor CCR2 OT - monocyte chemoattractant protein-1 OT - monocyte subtypes OT - myocardial infarction EDAT- 2017/06/02 06:00 MHDA- 2017/08/29 06:00 CRDT- 2017/06/02 06:00 PHST- 2017/01/06 00:00 [received] PHST- 2017/02/17 00:00 [revised] PHST- 2017/02/24 00:00 [accepted] PHST- 2017/06/02 06:00 [entrez] PHST- 2017/06/02 06:00 [pubmed] PHST- 2017/08/29 06:00 [medline] AID - CS20170009 [pii] AID - 10.1042/CS20170009 [doi] PST - ppublish SO - Clin Sci (Lond). 2017 Jun 1;131(12):1215-1224. doi: 10.1042/CS20170009.